Related Experiment Video
Updated: Jul 2, 2025

07:36
Autofluorescence Imaging to Evaluate Cellular Metabolism
Published on: November 15, 2021
4.2K
Artificial Intelligence in Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) Data Analysis-Toward Retinal Metabolic
Natalie Thiemann1, Svenja Rebecca Sonntag2, Marie Kreikenbohm2
1Institute for Neuro- and Bioinformatics, University of Lübeck, 23538 Lübeck, Germany.
Diagnostics (Basel, Switzerland)
|February 24, 2024
Summary
Artificial intelligence (AI) can analyze fluorescence lifetime imaging ophthalmoscopy (FLIO) data from healthy individuals, even with small datasets. AI, specifically support vector machines, achieved 80% accuracy in distinguishing smokers from non-smokers using FLIO data.
Area of Science:
- Ophthalmology
- Medical Imaging
- Artificial Intelligence
Background:
- Fluorescence lifetime imaging ophthalmoscopy (FLIO) provides functional information about the retina.
- Analyzing FLIO data, especially from healthy subjects with small datasets, presents a challenge.
- Artificial intelligence (AI) offers potential solutions for complex data analysis in medical imaging.
Purpose of the Study:
- To investigate the feasibility of using AI for analyzing FLIO data, particularly with small sample sizes.
- To evaluate the effectiveness of different AI methods, including support vector machines (SVMs), convolutional neural networks (CNNs), and autoencoder networks.
- To assess AI's capability in differentiating between smokers and non-smokers based on FLIO parameters.
Main Methods:
- Utilized FLIO data (fluorescence intensity, mean fluorescence lifetime τm) and OCT-A data from 26 non-smokers and 28 smokers.
- Applied SVM, CNN, and autoencoder networks for data analysis.
- Focused on analyzing τm in two spectral channels.
Main Results:
- SVM successfully distinguished mean fluorescence lifetime (τm) between non-smokers and heavy smokers with approximately 80% accuracy.
- CNN and autoencoder networks did not achieve significant differentiation.
- Optical Coherence Tomography Angiography (OCT-A) data showed no significant differences between groups.
Conclusions:
- AI, particularly SVM, is feasible and useful for analyzing FLIO data from healthy subjects, even with small datasets.
- AI-assisted FLIO shows promise for advancing early retinal diagnosis.
- Further validation with larger datasets is recommended to confirm these findings.

